WeLeader Biomedical Co., Ltd. (7713)
TWSE
73.80
-0.20 (-0.27%)
Closed
Sep 24, 2026
Day's Range
73.8074.50
52 wk Range
66.0081.10
Financial Statements - 7713 - WeLeader Biomedical Co., Ltd.
Revenue
1.10B▲ 11.9%
Net Income
208.55M▲ 22.5%Net Margin 18.8%
EBITDA
393.06M▲ 19.2%
Free Cash Flow
99.55M▼ 4.7%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Sales | 1.10B | 991.12M | 940.69M | 1.03B | 841.14M | 674.54M |
| Cost of Goods | 738.33M | 674.80M | 642.62M | 743.97M | 622.21M | 517.94M |
| Gross Profit | 370.96M | 316.32M | 298.07M | 291.74M | 218.92M | 156.59M |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | 261.12M | 214.19M | 197.48M | 194.10M | 132.66M | 67.97M |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | - | - | - | - | - | - |
| Pre Tax Income | 260.98M | 215.20M | 193.54M | 192.54M | 131.45M | 61.27M |
| Income Tax | 52.42M | 44.99M | 41.26M | 38.74M | 25.68M | 12.19M |
| Net Income | 208.55M | 170.21M | 152.28M | 153.79M | 105.77M | 49.07M |
| EPS Basic | 4.64 | 4.09 | 3.74 | 4.4 | 3.79 | 1.180336 |
| EPS Diluted | 4.52 | 4.08 | 3.71 | 4.34 | 3.76 | 1.180336 |
| Basic Shares Outstanding | 44.94M | 41.57M | 40.71M | 34.95M | 27.88M | 41.57M |
| Diluted Shares Outstanding | 44.94M | 41.57M | 40.71M | 34.95M | 27.88M | 41.57M |
| Ebit | 269M | 221M | 199.23M | 196.75M | 137.62M | 69.86M |
| Ebitda | 393.06M | 329.64M | 302.55M | 306.04M | 252.45M | 178.63M |
| Net Income Continuous Operations | 260.98M | 215.20M | 193.54M | 192.54M | 131.45M | 61.27M |
| Minority Interests | - | - | - | - | - | - |
| Preferred Stock Dividends | 0 | 0 | 0 | 0 | 0 | 0 |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
